The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Link
https://link.springer.com/content/pdf/10.1007/s40264-022-01256-2.pdf
Reference28 articles.
1. Determination of Public Health Emergency. https://www.federalregister.gov/documents/2020/02/07/2020-02496/determination-of-public-health-emergency. Accessed 25 Mar 2022.
2. Notice of Emergency Use Authorization Declaration. https://www.federalregister.gov/documents/2020/04/01/2020-06905/emergency-use-authorization-declaration. Accessed 25 Mar 2022.
3. Sorbello A, Jones SC, Carter W, et al. Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus. Clin Infect Dis. 2012;55(1):1–7. https://doi.org/10.1093/cid/cis351.
4. Cocoros NM, Fuller CC, Adimadhyam S, et al. A COVID-19-ready public health surveillance system: the Food and Drug Administration’s Sentinel System. Pharmacoepidemiol Drug Saf. 2021;30(7):827–37. https://doi.org/10.1002/pds.5240.
5. WHO-UMC system for standardization case causality assessment. http://www.who-umc.org/. Accessed 14 Oct 2022.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study;Drug Safety;2024-02-14
2. Impact of the COVID-19 pandemic on the spontaneous reporting and signal detection of adverse drug events;Scientific Reports;2023-11-01
3. Pyronaridine tetraphosphate is an efficacious antiviral and anti-inflammatory active against multiple highly pathogenic coronaviruses;mBio;2023-10-31
4. Strengthening regulatory systems globally: a crucial step towards pandemic preparedness and response;BMJ Global Health;2023-08
5. Nanobodies against SARS-CoV-2 reduced virus load in the brain of challenged mice and neutralized Wuhan, Delta and Omicron Variants;2023-03-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3